Search

Tvardi Therapeutics Inc

Geschlossen

4.64 3.57

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.31

Max

4.72

Tvardi Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

14. Jan. 2026, 22:41 UTC

Akquisitionen, Fusionen, Übernahmen

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15. Jan. 2026, 00:00 UTC

Ergebnisse

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14. Jan. 2026, 23:47 UTC

Market Talk

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14. Jan. 2026, 23:44 UTC

Market Talk

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14. Jan. 2026, 23:39 UTC

Market Talk

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14. Jan. 2026, 23:32 UTC

Market Talk

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14. Jan. 2026, 22:56 UTC

Akquisitionen, Fusionen, Übernahmen

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14. Jan. 2026, 22:53 UTC

Akquisitionen, Fusionen, Übernahmen

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14. Jan. 2026, 22:17 UTC

Market Talk

Global Equities Roundup: Market Talk

14. Jan. 2026, 22:17 UTC

Market Talk

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14. Jan. 2026, 22:09 UTC

Ergebnisse

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14. Jan. 2026, 22:08 UTC

Ergebnisse

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14. Jan. 2026, 22:08 UTC

Ergebnisse

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14. Jan. 2026, 21:53 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14. Jan. 2026, 21:53 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14. Jan. 2026, 21:52 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC Announces Positive Profit Alert for 2025

14. Jan. 2026, 21:51 UTC

Akquisitionen, Fusionen, Übernahmen

Citigroup Acting as Financial Advisor to WuXi XDC

14. Jan. 2026, 21:51 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC: Aims to Keep Listing Status of BioDlink

14. Jan. 2026, 21:51 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14. Jan. 2026, 21:50 UTC

Market Talk
Ergebnisse

Financial Services Roundup: Market Talk

14. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14. Jan. 2026, 21:49 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14. Jan. 2026, 21:48 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14. Jan. 2026, 21:48 UTC

Akquisitionen, Fusionen, Übernahmen

WuXi XDC Makes Cash Offer for BioDlink International

14. Jan. 2026, 21:13 UTC

Market Talk

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14. Jan. 2026, 20:30 UTC

Market Talk
Ergebnisse

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14. Jan. 2026, 20:13 UTC

Market Talk

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14. Jan. 2026, 20:08 UTC

Market Talk

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14. Jan. 2026, 19:33 UTC

Market Talk

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14. Jan. 2026, 19:06 UTC

Market Talk
Ergebnisse

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Tvardi Therapeutics Inc Prognose

Finanzen

$

help-icon Live chat